Unmasking influenza virus infection in patients attended to in the emergency department

Infection

Volumn 32, Issue 2, 2004, Pages 89-97

  Monmany, J ^a,b   Rabella, N ^b   Margall, N ^b   Domingo, P ^a   Gich, I ^b   Vazquez G ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b Hospital of Santa Creu i Sant Pau   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CYTOKINE; INFLUENZA VACCINE;

ADULT; AGE; ANTIBIOTIC THERAPY; ANTIGEN DETECTION; ARTICLE; CHARLSON SCALE; CLINICAL FEATURE; COMORBIDITY; COUGHING; DELIRIUM; DETERIORATION; DIARRHEA; DYSPNEA; EMERGENCY WARD; EPIDEMIC; EPIGASTRIC PAIN; FALLING; FEMALE; FEVER; HEADACHE; HEMOPTYSIS; HOSPITALIZATION; HUMAN; IMMUNOFLUORESCENCE; INCONTINENCE; INFECTION COMPLICATION; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; JAUNDICE; MAJOR CLINICAL STUDY; MALAISE; MALE; MYALGIA; OBSERVATION; PAIN; PATIENT CODING; PREDICTION; PROSPECTIVE STUDY; RATING SCALE; SPAIN; SYMPTOM; SYNCOPE; THERMOREGULATION; THROAT CULTURE; UNIVERSITY HOSPITAL; VIRUS DETECTION; VIRUS DIAGNOSIS; VOMITING;

ADULT; AGE DISTRIBUTION; AGED; EMERGENCY SERVICE, HOSPITAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; ORTHOMYXOVIRIDAE; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; RISK ASSESSMENT; SAMPLING STUDIES; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SPAIN; STATISTICS, NONPARAMETRIC;

EID: 1842556557     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/s15010-004-3088-y     Document Type: Article

References (43)

1. Simonsen L, Clarke MJ, Williamson GD, Stroup DF, Arden NH, Schonberger LB:The impact of influenza epidemics on mortality: introducing a severity index. Am J Public Health 1997; 87: 1944-1950.
2. Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR:The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. N Engl J Med 2000; 342: 225-231.
3. Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K: Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J Infect Dis 1998; 178: 53-60.
4. Neuzil KM, Reed GW, Mitchel EF, Griffin MR: Influenza-associated morbidity and mortality in young and middle-aged women. JAMA 1999; 281: 901-907.
5. Govaert TM, Dinant GJ, Aretz K, Knottnerus JA: The predictive value of influenza symptomatology in elderly people. Fam Pract 1998; 15: 16-22.
6. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J: Clinical signs and symptoms predicting influenza infection. Arch Intern Med 2000; 160: 3243-3247.
7. Cate TR: Clinical manifestations and consequences of influenza. Am J Med 1987; 82: 15-19.
8. Treanor JJ, Hayden FG, Vrooman PS, Barbarash R, Bettis R, Riff D, Singh S, Kinnersley N, Ward P, Mills RG: Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: a randomized controlled trial. US Oral Neuraminidase Study Group. JAMA 2000; 283: 1016-1024.
9. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern HemisphereTrialists) Study Group. Lancet 1998; 352: 1877-1881.
10. Rapid laboratory techniques for the diagnosis of viral infections. World Health Organ Tech Rep Ser 1981, pp 1-60.
11. Carlini ME, Wayne SX: Infectious diseases: viral & rickettsial. Influenza. In: Tierney LM, McPhee SJ, Papadakis MA (eds): Current Medical Diagnosis & Treatment 2001. Lange Medical Books/McGraw-Hill, New York 2001, pp 1334-1336.
12. PIDIRAC, Pla d'informació diària de les infeccions respiratòries agudes a Catalunya: Activitat gripal a Catalunya. Temporada 1999-2000. Butlletí epidemiològic de Catalunya 2000; 21: 71-77.
13. Laboratory Diagnosis of Influenza. Sino-Danish Postgraduate Training Center, Beijing, China 1999.
14. Hopkins PM, Plit ML, Carter IW, Chajed PN, Malouf MA, Glanville AR: Indirect fluorescent antibody testing of nasopharyngeal swabs for influenza diagnosis in lung transplant recipients. J Heart Lung Transplant 2003; 22: 161-168.
15. Manuguerra JC, Hannoun C: Influenza and other viral respiratory diseases. Surveillance and laboratory diagnosis. Coordination des laboratoires de référence et d'expertise. Méthodes de laboratoire. Paris 1999.
16. Dolin R: Influenza: current concepts. Am Fam Physician 1976; 14: 72-77
17. Noyola DE, Clark B, O'Donnell FT, Atmar RL, Greer J, Demmler GJ: Comparison of a new neuraminidase detection assay with an enzyme immunoassay, immunofluorescence, and culture for rapid detection of influenza A and B viruses in nasal wash specimens. J Clin Microbiol 2000; 38: 1161-1165.
18. Savy VL, Baumeister EG, Campos AM, Pontoriero A: Comparison of 2 techniques for the laboratory diagnosis of influenza virus infections. Rev Argent Microbiol 2000; 32: 144-148.
19. Dominguez EA, Taber LH, Couch RB: Comparison of rapid diagnostic techniques for respiratory syncytlal and influenza A virus respiratory infections in young children. J Clin Microbiol 1993; 31: 2286-2290.
20. Waner JL, Todd SJ, Shalaby H, Murphy P, Wall LV: Comparison of Directigen FLU-A with viral isolation and direct immunofluorescence for the rapid detection and identification of influenza A virus. J Clin Microbiol 1991; 29: 479-482.
21. Doing KM, Jerkofsky MA, Dow EG, Jellison JA: Use of fluorescent-antibody staining of cytocentrifuge-prepared smears in combination with cell culture for direct detection of respiratory viruses. J Clin Microbiol 1998; 36: 2112-2114.
22. Gardner PS, McQuillin J: Rapid virus diagnosis: Applications of immunofluorescence. Butterworths, London 1980.
23. Madeley CR, Peiris JS: Methods in virus diagnosis: immunofluorescence revisited. J Clin Virol 2002; 25: 121-134.
24. Connolly AM, Salmon RL, Lervy B, Williams DH: What are the complications of influenza and can they be prevented? Experience from the 1989 epidemic of H3N2 influenza A in general practice. BMJ 1993; 306: 1452-1454.
25. Doyle WJ, Alper CM, Buchman CA, Moody SA, Skoner DP, Cohen S: Illness and otological changes during upper respiratory virus infection. Laryngoscope 1999; 109: 324-328.
26. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383.
27. Armitage P, Berry G: Statistical methods in medical research. Blackwell Scientific Publications, Oxford 1994.
28. Hosmer DWJ, Lemeshow S: Applied logistic regression. John Wiley & Sons Inc, New York, NY 1989.
29. Kaiser L, Fritz RS, Straus SE, Gubareva L, Hayden FG: Symptom pathogenesis during acute influenza: interleukin-6 and other cytokine responses. J Med Virol 2001; 164: 262-268.
30. Upshur RE, Goel V: Measuring the impact of influenza on the hospital admission rates of the elderly in Ontario: a five-year admission rate analysis, 1988-1993. Can J Public Health 2000; 91: 144-147.
31. Fleming DM: The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Commun Dis Public Health 2000; 3: 32-38.
32. Cox FM, Cobb MM, Chua WQ, McLaughlin TP, Okamoto LJ: Cost of treating influenza in emergency department and hospital settings. Am J Manag Care 2000; 6: 205-214.
33. Keitel WA, Cate TR, Couch RB, Huggins LL, Hess KR: Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine 1997; 15: 1114-1122.
34. Nexoe J, Kragstrup J, Ronne T: Impact of postal invitations and user fee on influenza vaccination rates among the elderly. A randomized controlled trial in general practice. Scand J Prim Health Care 1997; 15: 109-112.
35. Baker AM, McCarthy B, Gurley VF, Yood MU: Influenza immunization in a managed care organization. J Gen Intern Med 1998; 13: 469-475.
36. Armstrong K, Berlin M, Schwartz JS, Propert K, Ubel PA: Educational content and the effectiveness of influenza vaccination reminders. J Gen Intern Med 1999; 14: 695-698.
37. Boivin G, Goyette N, Hardy I, Aoki F, Wagner A, Trottier S: Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults. J Infect Dis 2000; 181: 1471-1474.
38. Matsumoto K, Ogawa N, Nerome K, Numazaki Y, Kawakami Y, Shirato K, Arakawa M, Kudoh S, Shimokata K, Nakajima S, Yamakido M, Kashiwagi S, Nagatake T: Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group. Antivir Ther 1999; 4: 61-68.
39. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG, Bohnen AM, Hirst HM, Keene O, Wightman K: Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group. N Engl J Med 1997; 337: 874-880.
40. Nicholson KG, Aoki FY, Osterhaus AD, Trottier S, Carewicz O, Mercier CH, Rode A, Kinnersley N, Ward P: Efficacy and safety of oseltamivir in treatment of acute influenza: a randomised controlled trial. Neuraminidase Inhibitor Flu Treatment Investigator Group. Lancet 2000; 355: 1845-1850.
41. There are two sides to biodefence. Nature 2003; 422: 545.
42. Ellis JS, Fleming DM, Zambon MC: Multiplex reverse transcription-PCR for surveillance of influenza A and B viruses in England and Wales in 1995 and 1996. J Clin Microbiol 1997; 35: 2076-2082.
43. Stockton J, Ellis JS, Saville M, Clewley JP, Zambon MC: Multiplex PCR for typing and subtyping influenza and respiratory syncytial viruses. J Clin Microbiol 1998; 36: 2990-2995.